CoChat

Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR)

Open access
European Society of Radiology, deSouza, Nandita M., Achten, Eric, Alberich-Bayarri, Angel, Bamberg, Fabian, Boellaard, Ronald, Clément, Olivier, Fournier, Laure, Gallagher, Ferdia, Golay, Xavier, Heussel, Claus Peter, Jackson, Edward F., Manniesing, Rashindra, Mayerhofer, Marius E., Neri, Emanuele, O’Connor, James, Oguz, Kader Karli, Persson, Anders, Smits, Marion, van Beek, Edwin J. R., Zech, Christoph J. · 2019 · Insights into Imaging
Cited by 105

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Observer-driven pattern recognition is the standard for interpretation of medical images. To achieve global parity in interpretation, semi-quantitative scoring systems have been developed based on observer assessments; these are widely used in scoring coronary artery disease, the arthritides and neurological conditions and for indicating the likelihood of malignancy. However, in an era of machine learning and artificial intelligence, it is increasingly desirable that we extract quantitative biomarkers from medical images that inform on disease detection, characterisation, monitoring and assessment of response to treatment. Quantitation has the potential to provide objective decision-support tools in the management pathway of patients. Despite this, the quantitative potential of imaging remains under-exploited because of variability of the measurement, lack of harmonised systems for data acquisition and analysis, and crucially, a paucity of evidence on how such quantitation potentially affects clinical decision-making and patient outcome. This article reviews the current evidence for the use of semi-quantitative and quantitative biomarkers in clinical settings at various stages of the disease pathway including diagnosis, staging and prognosis, as well as predicting and detecting treatment response. It critically appraises current practice and sets out recommendations for using imaging objectively to drive patient management decisions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13244-019-0764-0

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 177

  1. Mercado CL (2014) BI-RADS update. Radiol Clin North Am. 52:481–487 · DOI · Paper page
  2. Barentsz JO, Weinreb JC, Verma S et al (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol. 69:41–49 · DOI · Paper page
  3. Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL (2018) Artificial intelligence in radiology. Nat Rev Cancer. 18:500–510 · DOI · Paper page
  4. Zacho HD, Nielsen JB, Afshar-Oromieh A et al (2018) Prospective comparison of (68)Ga-PSMA PET/CT, (18)F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 45:1884–1897 · DOI
  5. Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 42:328–354 · DOI · Paper page
  6. O'Connor JP, Aboagye EO, Adams JE et al (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 14:169–186 · DOI · Paper page
  7. Zhuang M, Vallez Garcia D, Kramer GM et al (2018) Variability and repeatability of quantitative uptake metrics in [(18)F]FDG PET/CT imaging of non-small cell lung cancer: impact of segmentation method, uptake interval, and reconstruction protocol. J Nucl Med 60:600–607 · DOI
  8. Barrington SF, Kirkwood AA, Franceschetto A et al (2016) PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood. 127:1531–1538 · DOI · Paper page
  9. Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL (2018) Artificial intelligence in radiology. Nat Rev Cancer 18:500–510 · DOI · Paper page
  10. Trivedi SB, Vesoulis ZA, Rao R et al (2017) A validated clinical MRI injury scoring system in neonatal hypoxic-ischemic encephalopathy. Pediatric radiology. 47:1491–1499 · DOI · Paper page
  11. Machino M, Ando K, Kobayashi K et al (2018) Alterations in intramedullary T2-weighted increased signal intensity following laminoplasty in cervical spondylotic myelopathy patients: comparison between pre- and postoperative magnetic resonance images. Spine (Phila Pa 1976). 43:1595–1601 · DOI
  12. Chen CJ, Lyu RK, Lee ST, Wong YC, Wang LJ (2001) Intramedullary high signal intensity on T2-weighted MR images in cervical spondylotic myelopathy: prediction of prognosis with type of intensity. Radiology. 221:789–794 · DOI · Paper page
  13. Khanna D, Ranganath VK, Fitzgerald J et al (2005) Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage. Arthritis Rheum. 52:2284–2292 · DOI
  14. Jaremko JL, Azmat O, Lambert RGW et al (2017) Validation of a knowledge transfer tool according to the OMERACT filter: does web-based real-time iterative calibration enhance the evaluation of bone marrow lesions in hip osteoarthritis? J Rheumatol. 44:1713–1717 · doi:10.3899/jrheum.161101
  15. Molyneux PD, Miller DH, Filippi M et al (1999) Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility. Neuroradiology. 41:882–888 · DOI
  16. Stollfuss JC, Becker K, Sendler A et al (2006) Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens. Radiology. 241:132–141 · DOI
  17. Barrington SF, Mikhaeel NG, Kostakoglu L et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32:3048–3058 · DOI · Paper page
  18. Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) Version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830 · DOI · Paper page
  19. Elsayes KM, Hooker JC, Agrons MM et al (2017) 2017 version of LI-RADS for CT and MR imaging: an update. Radiographics. 37:1994–2017 · DOI · Paper page
  20. Tessler FN, Middleton WD, Grant EG et al (2017) ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 14:587–595 · DOI · Paper page
  21. Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 74:294–306 · DOI · Paper page
  22. Kitajima K, Tanaka U, Ueno Y et al (2015) Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumour. PLoS One. 10:e0117411 · doi:10.1371/journal.pone.0117411
  23. Cornelis F, Tricaud E, Lasserre AS et al (2015) Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol. 25:24–31 · DOI
  24. Martin MD, Kanne JP, Broderick LS, Kazerooni EA, Meyer CA (2017) Lung-RADS: pushing the limits. Radiographics. 37:1975–1993 · DOI
  25. Sabra MM, Sherman EJ (2017) Tumour volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma. Cancer 123:2955–2964 · DOI
  26. Kadir T, Gleeson F (2018) Lung cancer prediction using machine learning and advanced imaging techniques. Transl Lung Cancer Res. 7:304–312 · DOI · Paper page
  27. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247 · DOI · Paper page
  28. Yao GH, Zhang M, Yin LX et al (2016) Doppler Echocardiographic Measurements in Normal Chinese Adults (EMINCA): a prospective, nationwide, and multicentre study. Eur Heart J Cardiovasc Imaging. 17:512–522 · DOI
  29. Elgendy A, Seppelt IM, Lane AS (2017) Comparison of continous-wave Doppler ultrasound monitor and echocardiography to assess cardiac output in intensive care patients. Crit Care Resusc 19:222–229
  30. Figueiredo CP, Kleyer A, Simon D et al (2018) Methods for segmentation of rheumatoid arthritis bone erosions in high-resolution peripheral quantitative computed tomography (HR-pQCT). Semin Arthritis Rheum. 47:611–618 · doi:10.1016/j.semarthrit.2017.09.011
  31. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL (2001) The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 44:2009–2017 · DOI · Paper page
  32. Ødegård S1, Landewé R, van der Heijde D, Kvien TK, Mowinckel P, Uhlig T (2006) Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum. 54:68–75 · DOI · Paper page
  33. Marcus CD, Ladam-Marcus V, Cucu C, Bouche O, Lucas L, Hoeffel C (2009) Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol. 72:217–238 · DOI
  34. Levine ZH, Pintar AL, Hagedorn JG, Fenimore CP, Heussel CP (2012) Uncertainties in RECIST as a measure of volume for lung nodules and liver tumours. Med Phys. 39:2628–2637 · doi:10.1118/1.3701791
  35. Hawnaur JM, Johnson RJ, Buckley CH, Tindall V, Isherwood I (1994) Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol. 49:443–452 · doi:10.1016/s0009-9260(05)81738-6
  36. Soutter WP, Hanoch J, D'Arcy T, Dina R, McIndoe GA, DeSouza NM (2004) Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer. BJOG 111:741–747 · doi:10.1111/j.1471-0528.2004.00172.x
  37. Jiang Y, You K, Qiu X et al (2018) Tumour volume predicts local recurrence in early rectal cancer treated with radical resection: a retrospective observational study of 270 patients. Int J Surg 49:68–73 · doi:10.1016/j.ijsu.2017.11.052
  38. Tayyab M, Razack A, Sharma A, Gunn J, Hartley JE (2015) Correlation of rectal tumour volumes with oncological outcomes for low rectal cancers: does tumour size matter? Surg Today. 45:826–833 · doi:10.1007/s00595-014-1068-0
  39. Wagenaar HC, Trimbos JB, Postema S et al (2001) Tumour diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol. 82:474–482 · doi:10.1006/gyno.2001.6267
  40. Lee JW, Lee SM, Yun M, Cho A (2016) Prognostic value of volumetric parameters on staging and posttreatment FDG PET/CT in patients with stage IV non-small cell lung cancer. Clin Nucl Med. 41:347–353 · DOI
  41. Kurtipek E, Cayci M, Duzgun N et al (2015) (18)F-FDG PET/CT mean SUV and metabolic tumour volume for mean survival time in non-small cell lung cancer. Clin Nucl Med. 40:459–463 · DOI
  42. Meignan M, Cottereau AS, Versari A et al (2016) Baseline metabolic tumour volume predicts outcome in high-tumour-burden follicular lymphoma: a pooled analysis of three multicenter studies. J Clin Oncol. 34:3618–3626 · DOI · Paper page
  43. Meignan M, Itti E, Gallamini A, Younes A (2015) FDG PET/CT imaging as a biomarker in lymphoma. Eur J Nucl Med Mol Imaging. 42:623–633 · DOI
  44. Kanoun S, Tal I, Berriolo-Riedinger A et al (2015) Influence of software tool and methodological aspects of total metabolic tumour volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin lymphoma. PLoS One. 10:e0140830 · DOI · Paper page
  45. Kostakoglu L, Chauvie S (2018) Metabolic tumour volume metrics in lymphoma. Semin Nucl Med. 48:50–66 · DOI
  46. Mori S, Oishi K, Faria AV, Miller MI (2013) Atlas-based neuroinformatics via MRI: harnessing information from past clinical cases and quantitative image analysis for patient care. Annu Rev Biomed Eng. 15:71–92 · DOI
  47. Xu Y, Hosny A, Zeleznik R et al (2019) Deep learning predicts lung cancer treatment response from serial medical imaging. Clin Cancer Res. 25:3266–3275 · DOI · Paper page
  48. Ferraioli G, Wong VW, Castera L et al (2018) Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol. 44:2419–2440 · DOI · Paper page
  49. Lee SH, Chung J, Choi HY et al (2017) Evaluation of screening US-detected breast masses by combined use of elastography and color doppler US with B-Mode US in women with dense breasts: a multicenter prospective study. Radiology. 285:660–669 · doi:10.1148/radiol.2017162424
  50. Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2017) Shear-wave elastography for detection of prostate cancer: a systematic review and diagnostic meta-analysis. AJR Am J Roentgenol. 209:806–814 · DOI
  51. Du LJ, He W, Cheng LG, Li S, Pan YS, Gao J (2016) Ultrasound shear wave elastography in assessment of muscle stiffness in patients with Parkinson’s disease: a primary observation. Clin Imaging. 40:1075–1080 · DOI
  52. Ramnarine KV, Garrard JW, Kanber B, Nduwayo S, Hartshorne TC, Robinson TG (2014) Shear wave elastography imaging of carotid plaques: feasible, reproducible and of clinical potential. Cardiovasc Ultrasound. 12:49 · DOI
  53. Dori A, Abbasi H, Zaidman CM (2016) Intramuscular blood flow quantification with power doppler ultrasonography. Muscle Nerve. 54:872–878 · doi:10.1002/mus.25108
  54. Sieren JP, Newell JD Jr, Barr RG et al (2016) SPIROMICS protocol for multicenter quantitative computed tomography to phenotype the lungs. Am J Respir Crit Care Med. 194:794–806 · DOI · Paper page
  55. Keene JD, Jacobson S, Kechris K et al (2017) Biomarkers predictive of exacerbations in the SPIROMICS and COPDGene cohorts. Am J Respir Crit Care Med. 195:473–481 · DOI
  56. Andrade J, Schwarz M, Collard HR et al (2015) The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes. Chest. 148:1034–1042 · DOI
  57. Washko GR, Diaz AA, Kim V et al (2014) Computed tomographic measures of airway morphology in smokers and never-smoking normals. J Appl Physiol (1985). 116:668–673 · DOI
  58. Jarjour NN, Erzurum SC, Bleecker ER et al (2012) Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med. 185:356–362 · DOI · Paper page
  59. Schuhmann M, Raffy P, Yin Y et al (2015) Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med. 191:767–774 · DOI
  60. Van Der Molen MC, Klooster K, Hartman JE, Slebos DJ (2018) Lung volume reduction with endobronchial valves in patients with emphysema. Expert Rev Med Devices. 15:847–857 · DOI
  61. Salisbury ML, Lynch DA, van Beek EJ et al (2017) Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes. Am J Respir Crit Care Med. 195:921–929 · DOI · Paper page
  62. Goyal M, Menon BK, Derdeyn CP (2013) Perfusion imaging in acute ischaemic stroke: let us improve the science before changing clinical practice. Radiology. 266:16–21 · DOI
  63. Guo J, Wang C, Chan KS et al (2016) A controlled statistical study to assess measurement variability as a function of test object position and configuration for automated surveillance in a multicenter longitudinal COPD study (SPIROMICS). Med Phys. 43:2598 · doi:10.1118/1.4947303
  64. Rodriguez A, Ranallo FN, Judy PF, Fain SB (2017) The effects of iterative reconstruction and kernel selection on quantitative computed tomography measures of lung density. Med Phys. 44:2267–2280 · DOI
  65. Al-Mallah MH (2018) Coronary artery calcium scoring: do we need more prognostic data prior to adoption in clinical practice? JACC Cardiovasc Imaging. 11:1807–1809 · DOI
  66. Hoffmann U, Ferencik M, Udelson JE et al (2017) Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation. 135:2320–2332 · DOI · Paper page
  67. Altenbernd J, Wetter A, Umutlu L et al (2016) Dual-energy computed tomography for evaluation of pulmonary nodules with emphasis on metastatic lesions. Acta Radiol 57:437–443 · doi:10.1177/0284185115582060
  68. Lennartz S, Le Blanc M, Zopfs D et al (2019) Dual-energy CT derived iodine maps: use in assessing pleural carcinomatosis. Radiology. 290:796–804 · doi:10.1148/radiol.2018181567
  69. Barker P, Golay X, Zaharchuk G (2013) Clinical perfusion MRI: techniques and applications. Cambridge University Press. · doi:10.1017/cbo9781139004053
  70. Bittencourt LK, de Hollanda ES, de Oliveira RV (2016) Multiparametric MR imaging for detection and locoregional staging of prostate cancer. Top Magn Reson Imaging. 25:109–117 · doi:10.1097/rmr.0000000000000089
  71. Lopci E, Franzese C, Grimaldi M et al (2015) Imaging biomarkers in primary brain tumours. Eur J Nucl Med Mol Imaging. 42:597–612 · DOI
  72. Bollineni VR, Kramer G, Liu Y, Melidis C, deSouza NM (2015) A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer. Cancer Treat Rev 41:496–502 · doi:10.1016/j.ctrv.2015.03.010
  73. Galban CJ, Hoff BA, Chenevert TL, Ross BD (2017) Diffusion MRI in early cancer therapeutic response assessment. NMR Biomed. 30 · DOI
  74. Shukla-Dave A, Obuchowski NA, Chenevert TL et al (2018) Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 49:e101–e121 · DOI · Paper page
  75. Zeng Q, Shi F, Zhang J, Ling C, Dong F, Jiang B (2018) A modified tri-exponential model for multi-b-value diffusion-weighted imaging: a method to detect the strictly diffusion-limited compartment in brain. Front Neurosci 12:102 · DOI
  76. Langkilde F, Kobus T, Fedorov A et al (2018) Evaluation of fitting models for prostate tissue characterization using extended-range b-factor diffusion-weighted imaging. Magn Reson Med. 79:2346–2358 · DOI
  77. Winfield JM, Tunariu N, Rata M et al (2017) Extracranial soft-tissue tumours: repeatability of apparent diffusion coefficient estimates from diffusion-weighted MR imaging. Radiology 284:88–99 · DOI
  78. Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M (2016) T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging. 9:67–81 · DOI · Paper page
  79. Toussaint M, Gilles RJ, Azzabou N et al (2015) Characterization of benign myocarditis using quantitative delayed-enhancement imaging based on Molli T1 mapping. Medicine (Baltimore). 94:e1868 · DOI
  80. Jurcoane A, Wagner M, Schmidt C et al (2013) Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis. J Magn Reson Imaging. 38:1454–1461 · DOI
  81. Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 46:277–283 · doi:10.1097/rli.0b013e318200f67d
  82. Adam SZ, Nikolaidis P, Horowitz JM et al (2016) Chemical shift MR imaging of the adrenal gland: principles, pitfalls, and applications. Radiographics. 36:414–432 · DOI
  83. Yang L, Ding Y, Rao S et al (2017) Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid-enhanced MRI: comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4. J Magn Reson Imaging 45:1186–1194 · doi:10.1002/jmri.25440
  84. McDonald N, Eddowes PJ (2018) Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Sci Rep 8:9189 · DOI · Paper page
  85. Serai SD, Obuchowski NA, Venkatesh SK et al (2017) Repeatability of MR elastography of liver: a meta-analysis. Radiology. 285:92–100 · DOI · Paper page
  86. Tietze A, Blicher J, Mikkelsen IK et al (2014) Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI. NMR Biomed. 27:163–174 · DOI · Paper page
  87. Donahue MJ, Donahue PC, Rane S et al (2016) Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI. Magn Reson Med. 75:345–355 · doi:10.1002/mrm.25649
  88. Krishnamoorthy G, Nanga RPR, Bagga P, Hariharan H, Reddy R (2017) High quality three-dimensional gagCEST imaging of in vivo human knee cartilage at 7 Tesla. Magn Reson Med. 77:1866–1873 · DOI
  89. Lindeman LR, Randtke EA, High RA, Jones KM, Howison CM, Pagel MD (2018) A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH. Magn Reson Med. 79:2766–2772 · DOI
  90. David S, Visvikis D, Roux C, Hatt M (2011) Multi-observation PET image analysis for patient follow-up quantitation and therapy assessment. Phys Med Biol. 56:5771–5788 · doi:10.1088/0031-9155/56/18/001
  91. McDonald JE, Kessler MM, Gardner MW et al (2017) Assessment of total lesion glycolysis by (18)F FDG PET/CT significantly improves prognostic value of GEP and ISS in myeloma. Clin Cancer Res 23:1981–1987 · DOI
  92. Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50(Suppl 1):11s–20s · DOI · Paper page
  93. Boellaard R, O'Doherty MJ, Weber WA et al (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 37:181–200 · DOI · Paper page
  94. Kaalep A, Sera T, Rijnsdorp S et al (2018) Feasibility of state of the art PET/CT systems performance harmonisation. Eur J Nucl Med Mol Imaging. 45:1344–1361 · DOI · Paper page
  95. Hoffmann R, von Bardeleben S, ten Cate F et al (2005) Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J. 26:607–616 · DOI · Paper page
  96. Donal E, Delgado V, Magne J et al (2017) Rational and design of EuroCRT: an international observational study on multi-modality imaging and cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging. 18:1120–1127 · DOI
  97. de Amorim Paiva CC, de Mello Junior CF, Guimaraes Filho HA et al (2014) Reproducibility of renal volume measurement in adults using 3-dimensional sonography. J Ultrasound Med 33:431–435 · DOI
  98. Di Leo G, Di Terlizzi F, Flor N, Morganti A, Sardanelli F (2011) Measurement of renal volume using respiratory-gated MRI in subjects without known kidney disease: intraobserver, interobserver, and interstudy reproducibility. Eur J Radiol. 80:e212–e216 · DOI
  99. Veyrieres JB, Albarel F, Lombard JV et al (2012) A threshold value in Shear Wave elastography to rule out malignant thyroid nodules: a reality? Eur J Radiol. 81:3965–3972 · DOI · Paper page
  100. Chang CY, Chang SJ, Chang SC, Yuan MK (2013) The value of positron emission tomography in early detection of lung cancer in high-risk population: a systematic review. Clin Respir J. 7:1–6 · doi:10.1111/j.1752-699x.2012.00290.x
  101. Martinez CH, Chen YH, Westgate PM et al (2012) Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax. 67:399–406 · DOI
  102. Lynch DA, Moore CM, Wilson C et al (2018) CT-based visual classification of emphysema: association with mortality in the COPDGene study. Radiology. 288:859–866 · DOI · Paper page
  103. Jacob J, Bartholmai BJ, Rajagopalan S et al (2017) Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J. 49 · DOI · Paper page
  104. Jovin TG, Saver JL, Ribo M et al (2017) Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods. Int J Stroke. 12:641–652 · DOI · Paper page
  105. van Riel SJ, Ciompi F, Jacobs C et al (2017) Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines. Eur Radiol. 27:4019–4029 · doi:10.1007/s00330-017-4767-2
  106. Heuvelmans MA, Walter JE, Vliegenthart R et al (2018) Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening. Thorax. 73:779–781 · doi:10.1136/thoraxjnl-2017-210770
  107. Matoba M, Tsuji H, Shimode Y, Nagata H, Tonami H (2018) Diagnostic performance of adaptive 4D volume perfusion CT for detecting metastatic cervical lymph nodes in head and neck squamous cell carcinoma. AJR Am J Roentgenology. 211:1106–1111 · doi:10.2214/ajr.17.19241
  108. Zhang D, Xu A (2017) Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer. Oncol Lett. 14:5753–5758
  109. Timmers JM, van Doorne-Nagtegaal HJ, Zonderland HM et al (2012) The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool. Eur Radiol 22:1717–1723 · doi:10.1007/s00330-012-2409-2
  110. Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y (2017) A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol. 27:5204–5214 · DOI
  111. van der Pol CB, Lim CS, Sirlin CB et al (2019) Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy-a systematic review. Gastroenterology. 156:976–986 · DOI · Paper page
  112. deSouza NM, Winfield JM, Waterton JC et al (2018) Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. Eur Radiol 28:1118–1131 · DOI
  113. Hu Y, Tang H, Li H et al (2018) Assessment of different mathematical models for diffusion-weighted imaging as quantitative biomarkers for differentiating benign from malignant solid hepatic lesions. Cancer Med. https://doi.org/10.1002/cam4.1535 . [Epub ahead of print] · doi:10.1002/cam4.1535
  114. Bao J, Wang X, Hu C, Hou J, Dong F, Guo L (2017) Differentiation of prostate cancer lesions in the transition zone by diffusion-weighted MRI. Eur J Radiol Open. 4:123–128 · doi:10.1016/j.ejro.2017.08.003
  115. Nael K, Bauer AH, Hormigo A et al (2018) Multiparametric MRI for differentiation of radiation necrosis from recurrent tumour in patients with treated glioblastoma. AJR Am J Roentgenol 210:18–23 · doi:10.2214/ajr.17.18003
  116. Bastiaannet E, Groen H, Jager PL et al (2004) The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev. 30:83–101 · DOI · Paper page
  117. van Dijk LV, Brouwer CL, van der Laan HP et al (2017) Geometric image biomarker changes of the parotid gland are associated with late xerostomia. Int J Radiat Oncol Biol Phys. 99:1101–1110 · DOI
  118. Lu SJ, Gnanasegaran G, Buscombe J, Navalkissoor S (2013) Single photon emission computed tomography/computed tomography in the evaluation of neuroendocrine tumours: a review of the literature. Nucl Med Commun 34:98–107 · DOI
  119. Ambrosini V, Campana D, Tomassetti P, Fanti S (2012) 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. Eur J Nucl Med Mol Imaging. 39(Suppl 1):S52–S60 · DOI
  120. Maxwell JE, Howe JR (2015) Imaging in neuroendocrine tumours: an update for the clinician. Int J Endocr Oncol. 2:159–168 · DOI
  121. Gabriel M, Decristoforo C, Kendler D et al (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumours: comparison with somatostatin receptor scintigraphy and CT. J Nuclear Med 48:508–518 · DOI · Paper page
  122. Park SY, Zacharias C, Harrison C et al (2018) Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancer. Radiology 288:495–505 · DOI
  123. Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446 · DOI · Paper page
  124. Yip SS, Aerts HJ (2016) Applications and limitations of radiomics. Phys Med Biol. 61:R150–R166 · DOI · Paper page
  125. Lu M, Zhan X (2018) The crucial role of multiomic approach in cancer research and clinically relevant outcomes. EPMA J 9:77–102 · DOI · Paper page
  126. Zhao B, Tan Y, Tsai WY et al (2016) Reproducibility of radiomics for deciphering tumour phenotype with imaging. Sci Rep. 6:23428 · DOI · Paper page
  127. Peerlings J, Woodruff H, Winfield J et al (2019) Stability of radiomics features in apparent diffusion coefficient maps from a multi-centre test-retest trial. Sci Rep 9(1):4800 · DOI · Paper page
  128. Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25 · DOI · Paper page
  129. Cho I, Al’Aref SJ, Berger A et al (2018) Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study. Eur Heart J. 39:934–941 · DOI · Paper page
  130. Dweck MR, Chow MW, Joshi NV et al (2012) Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 59:1539–1548 · DOI · Paper page
  131. Pawade TA, Cartlidge TR, Jenkins WS et al (2016) Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis. Circ Cardiovasc imaging. 9 · DOI
  132. Joshi NV, Vesey AT, Williams MC et al (2014) 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 383:705–713 · DOI · Paper page
  133. Forsythe RO, Dweck MR, McBride OMB et al (2018) 18F-sodium fluoride uptake in abdominal aortic aneurysms: the SoFIA3 study. J Am Coll Cardiol. 71:513–523 · DOI · Paper page
  134. Mesaros S, Rocca M, Sormani M et al (2010) Bimonthly assessment of magnetisation transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. Mult Scler 16:325–331 · DOI
  135. Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M (2006) Magnetisation transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 129:2620–2627 · DOI · Paper page
  136. Rovaris M, Agosta F, Sormani MP et al (2003) Conventional and magnetisation transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 126:2323–2332 · DOI
  137. Deantonio L, Caroli A, Puta E et al (2018) Does baseline [18F] FDG-PET/CT correlate with tumour staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Radiat Oncol 13:211 · DOI
  138. Pan L, Gu P, Huang G, Xue H, Wu S (2009) Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. European journal of gastroenterology & hepatology. 21:1008–1015 · DOI
  139. Lewis S, Besa C, Wagner M et al (2018) Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging. Eur Radiol. 28:2047–2057 · DOI
  140. Wang YT, Li YC, Yin LL, Pu H (2016) Can diffusion-weighted magnetic resonance imaging predict survival in patients with cervical cancer? A meta-analysis. Eur J Radiol. 85:2174–2181 · DOI
  141. Yu AC, Badve C, Ponsky LE et al (2017) Development of a combined MR fingerprinting and diffusion examination for prostate cancer. Radiology. 283:729–738 · DOI · Paper page
  142. Delgado AF, Delgado AF (2017) Discrimination between glioma grades II and III using dynamic susceptibility perfusion MRI: a meta-analysis. AJNR Am J Neuroradiol 38:1348–1355 · DOI
  143. Su C, Liu C, Zhao L et al (2017) Amide proton transfer imaging allows detection of glioma grades and tumor proliferation: comparison with Ki-67 expression and proton MR spectroscopy imaging. AJNR Am J Neuroradiol. 38(9):1702–1709 · DOI
  144. Hayano K, Shuto K, Koda K, Yanagawa N, Okazumi S, Matsubara H (2009) Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer. Dis Colon Rectum. 52:1624–1629 · DOI
  145. Win T, Miles KA, Janes SM et al (2013) Tumour heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 19:3591–3599 · DOI · Paper page
  146. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2017) Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer. Acta Oncol 56:675–681 · DOI
  147. Fasmer KE, Bjornerud A, Ytre-Hauge S (2018) Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. Acta Radiol 59:1010–1017 · DOI
  148. Yu J, Xu Q, Huang DY et al (2017) Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer. Eur Radiol. 27:1840–1847 · doi:10.1007/s00330-016-4532-y
  149. Wilson R, Devaraj A (2017) Radiomics of pulmonary nodules and lung cancer. Transl Lung Cancer Res. 6:86–91 · DOI · Paper page
  150. Lee JW, Lee SM (2018) Radiomics in oncological PET/CT: clinical applications. Nucl Med Mol Imaging. 52:170–189 · DOI
  151. Zhang Y, Oikonomou A, Wong A, Haider MA, Khalvati F (2017) Radiomics-based prognosis analysis for non-small cell lung cancer. Sci Rep. 7:46349 · DOI · Paper page
  152. Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 34:2157–2164 · DOI · Paper page
  153. Goldin JG, Kim GHJ, Tseng CH et al (2018) Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II. Ann Am Thorac Soc. 15:1286–1295 · DOI
  154. Peacock AJ, Crawley S, McLure L et al (2014) Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging. 7:107–114 · DOI
  155. Steinhoff G, Nesteruk J, Wolfien M et al (2017) Cardiac function improvement and bone marrow response -: outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133+ application after myocardial infarction. EBioMedicine 22:208–224. · DOI
  156. Schwartz LH, Seymour L, Litiere S et al (2016) RECIST 1.1 - standardisation and disease-specific adaptations: perspectives from the RECIST Working Group. Eur J Cancer 62:138–145 · DOI · Paper page
  157. Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumours. J Nucl Med 50(Suppl 1):122s–150s · DOI · Paper page
  158. Sormani MP, De Stefano N (2013) Defining and scoring response to IFN-beta in multiple sclerosis. Nat Rev Neurol. 9:504–512 · DOI
  159. Ostergaard M, Bird P, Gandjbakhch F et al (2015) The OMERACT MRI in arthritis working group - update on status and future research priorities. J Rheumatol. 42:2470–2472 · doi:10.3899/jrheum.141248
  160. Patel P, Baradaran H, Delgado D et al (2017) MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis. Neuro Oncol. 19:118–127 · DOI · Paper page
  161. van Dijken BRJ, van Laar PJ, Holtman GA, van der Hoorn A (2017) Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis. Eur Radiol. 27:4129–4144 · DOI · Paper page
  162. Maffione AM, Marzola MC, Capirci C, Colletti PM, Rubello D (2015) Value of 18F-FDG PET for predicting response to neoadjuvant therapy in rectal cancer: systematic review and meta-analysis. AJR Am J Roentgenology. 204:1261–1268 · DOI
  163. Martens RM, Noij DP, Ali M et al (2019) Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review. Oral Oncol. 88:75–83 · DOI
  164. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068 · DOI · Paper page
  165. Younes A, Hilden P, Coiffier B et al (2017) International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol. 28:1436–1447 · DOI · Paper page
  166. Dalm SU, Verzijlbergen JF, De Jong M (2017) Review: receptor targeted nuclear imaging of breast cancer. Int J Mol Sci 18 · DOI
  167. Bakht MK, Oh SW, Youn H, Cheon GJ, Kwak C, Kang KW (2017) Influence of androgen deprivation therapy on the uptake of PSMA-targeted agents: emerging opportunities and challenges. Nucl Med Mol Imaging 51:202–211 · DOI
  168. Hotker AM, Tarlinton L, Mazaheri Y et al (2016) Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: a comparison of morphological, volumetric and functional MRI parameters. Eur Radiol. 26:4303–4312 · DOI
  169. Partridge SC, Zhang Z, Newitt DC et al (2018) Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 Multicenter Trial. Radiology 289:618–627. · DOI · Paper page
  170. Hayano K, Okazumi S, Shuto K et al (2007) Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Oncol Rep. 18:901–908
  171. O'Connor JP, Jackson A, Parker GJ, Roberts C, Jayson GC (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol. 9:167–177 · DOI · Paper page
  172. Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumour treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753–1759 · DOI · Paper page
  173. El Alaoui-Lasmaili K, Faivre B (2018) Antiangiogenic therapy: markers of response, “normalization” and resistance. Crit Rev Oncol Hematol. 128:118–129 · DOI
  174. Sheikhbahaei S, Mena E, Yanamadala A et al (2017) The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer. AJR Am J Roentgenol. 208:420–433 · DOI
  175. Goense L, van Rossum PS, Reitsma JB et al (2015) Diagnostic performance of 18F-FDG PET and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis. J Nucl Med 56:995–1002 · DOI
  176. Sullivan DC, Obuchowski NA, Kessler LG et al (2015) Metrology standards for quantitative imaging biomarkers. Radiology. 277:813–825 · DOI · Paper page
  177. Waterton JC, Pylkkanen L (2012) Qualification of imaging biomarkers for oncology drug development. Eur J Cancer 48:409–415 · DOI

Cited by

See all 105

Metadata

Authors
European Society of Radiology, deSouza, N. M., Achten, E., Alberich-Bayarri, A., Bamberg, F., Boellaard, R., Clément, O., Fournier, L., Gallagher, F., Golay, X., Heussel, C. P., Jackson, E. F., Manniesing, R., Mayerhofer, M. E., Neri, E., O’Connor, J., Oguz, K. K., Persson, A., Smits, M., van Beek, E. J. R., & Zech, C. J.
Venue
Insights into Imaging
Published
2019-08-29
Volume
10
Issue
1
Pages
87-87
ISSN
1869-4101 (ISSN-L)
OpenAlex
W2971053592
Cited by
105
References
9
FWCI
6.90
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR). https://app.cochat.ai/papers/10.1186/s13244-019-0764-0
The paper
European Society of Radiology, deSouza, N. M., Achten, E., Alberich-Bayarri, A., Bamberg, F., Boellaard, R., Clément, O., Fournier, L., Gallagher, F., Golay, X., Heussel, C. P., Jackson, E. F., Manniesing, R., Mayerhofer, M. E., Neri, E., O’Connor, J., Oguz, K. K., Persson, A., Smits, M., . . . Zech, C. J. (2019). Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR). Insights into Imaging. https://doi.org/10.1186/s13244-019-0764-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.